Delayed methotrexate excretion in infants and young children with primary central nervous system tumors and postoperative fluid collections

PURPOSE: High-dose methotrexate (HD-MTX) has been used to treat children with central nervous system tumors. Accumulation of MTX within pleural, peritoneal, or cardiac effusions has led to delayed excretion and increased risk of systemic toxicity. This retrospective study analyzed the association of...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cancer Chemother Pharmacol
Hlavní autoři: Wright, Karen D., Panetta, John C., Onar-Thomas, Arzu, Reddick, Wilburn E., Patay, Zoltan, Qaddoumi, Ibrahim, Broniscer, Alberto, Robinson, Giles, Boop, Frederick A., Klimo, Paul, Ward, Deborah, Gajjar, Amar, Stewart, Clinton F.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2014
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4282603/
https://ncbi.nlm.nih.gov/pubmed/25342291
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00280-014-2614-6
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky